3.050USD+0.83%Mkt Cap: 331.40M USDP/E: —Last update: 2026-06-01
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing, manufacturing, and selling of genetic therapies for rare and devastating diseases i…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap331.40M USD
Enterprise Value215.61M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-223.12M USD
Revenue/Share—
Last Price3.050 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees202
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS77313F1066
Valuation
P/E (Trailing)—
P/E (Forward)-2.65
PEG—
EV/EBITDA-1.06
EV/Revenue—
P/S—
P/B1.41
EPS (TTM)-1.87
EPS (Forward)-1.16
52W Range
2.40021% of range5.450
52W High5.450 USD
52W Low2.400 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-80.49%
ROA-67.52%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-190.01M USD
CapEx (TTM)440.00K USD
FCF Margin—
FCF Yield-29.83%
Net Debt-119.62M USD
Net Debt/EBITDA0.59
Balance Sheet
Debt/Equity0.09
Current Ratio6.12
Quick Ratio5.90
Book Value/Sh2.181 USD
Cash/Share1.322 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJan 5, 2018
Splits
Last Split1:4
Split DateJan 5, 2018
Analyst Consensus
Rating—
Target (Mean)9.295 USD
Target Range3.000 USD – 16.00 USD
# Analysts11
Ownership
Shares Out.109.19M
Float87.51M
Insiders2.97%
Institutions89.87%
Short Interest
Short Ratio10.1d
Short % Float23.54%
Short % Out.19.19%
Shares Short20.95M
Short (prev mo.)19.08M
Technical
SMA 503.599 (-15.2%)
SMA 2003.574 (-14.7%)
Beta0.52
S&P 52W Chg27.70%
Avg Vol (30d)2.07M
Avg Vol (10d)2.33M
Technical Indicators
RSI (14)37.5
MACD-0.1954
MACD Signal-0.1793
MACD Hist.-0.0161
BB Upper3.950 USD
BB Middle3.320 USD
BB Lower2.690 USD
BB Width37.95%
ATR (14)0.2057 USD
Vol Ratio (20d)0.63x